Martin Štefanič

1.6k total citations
39 papers, 1.3k citations indexed

About

Martin Štefanič is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Martin Štefanič has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Martin Štefanič's work include Chronic Lymphocytic Leukemia Research (6 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Bone Tissue Engineering Materials (5 papers). Martin Štefanič is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Bone Tissue Engineering Materials (5 papers). Martin Štefanič collaborates with scholars based in Germany, Slovenia and Austria. Martin Štefanič's co-authors include Donald Bunjes, Peter Stopfer, H. Heimpel, Bernd Hertenstein, R. Kaiser, Markus Wiesneth, C. Buck, Franz Porzsolt, W. Digel and Tomaž Kosmac̆ and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biomaterials.

In The Last Decade

Martin Štefanič

38 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martin Štefanič Germany	20	351	349	319	305	252	39	1.3k
Joo Seop Chung South Korea	23	249 0.7×	515 1.5×	415 1.3×	296 1.0×	394 1.6×	101	1.8k
Masamichi Sugimoto Japan	19	175 0.5×	506 1.4×	140 0.4×	526 1.7×	365 1.4×	45	1.7k
Lewis Cohen United States	19	151 0.4×	511 1.5×	332 1.0×	423 1.4×	439 1.7×	41	1.9k
Sharon R. Hymes United States	22	174 0.5×	494 1.4×	431 1.4×	167 0.5×	415 1.6×	57	2.0k
T. E. Cawston United Kingdom	18	166 0.5×	374 1.1×	223 0.7×	317 1.0×	133 0.5×	28	1.6k
Xiaoyu Chai United States	23	398 1.1×	468 1.3×	945 3.0×	198 0.6×	296 1.2×	51	1.8k
George Deeb United States	21	338 1.0×	597 1.7×	324 1.0×	420 1.4×	203 0.8×	65	1.9k
Markéta Jiroušková United States	18	413 1.2×	582 1.7×	604 1.9×	352 1.2×	276 1.1×	32	1.8k
Tanya Trippett United States	24	263 0.7×	655 1.9×	380 1.2×	580 1.9×	197 0.8×	79	1.9k
Ralf Hildenbrand Germany	27	301 0.9×	1.0k 2.9×	162 0.5×	718 2.4×	335 1.3×	56	2.0k

Countries citing papers authored by Martin Štefanič

Since Specialization

Citations

This map shows the geographic impact of Martin Štefanič's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Štefanič with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Štefanič more than expected).

Fields of papers citing papers by Martin Štefanič

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Štefanič. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Štefanič. The network helps show where Martin Štefanič may publish in the future.

Co-authorship network of co-authors of Martin Štefanič

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Štefanič. A scholar is included among the top collaborators of Martin Štefanič based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Štefanič. Martin Štefanič is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Földesi, Csaba, Marcin Kuniewicz, Petr Neužil, et al.. (2024). Electrophysiology lab efficiency using cryoballoon for pulmonary vein isolation in central and eastern Europe: A sub-analysis of the cryo global registry study. Cardiology Journal. 31(5). 656–664.

Babić, Marija M., Marija Vukomanović, Martin Štefanič, Jasmina Nikodinović‐Runić, & Simonida Lj. Tomić. (2020). Controlled Curcumin Release from Hydrogel Scaffold Platform Based on 2‐Hydroxyethyl Methacrylate/Gelatin/Alginate/Iron(III) Oxide. Macromolecular Chemistry and Physics. 221(20). 10 indexed citations

Štefanič, Martin & Tomaž Kosmac̆. (2018). β-TCP coatings on zirconia bioceramics: The importance of heating temperature on the bond strength and the substrate/coating interface. Journal of the European Ceramic Society. 38(15). 5264–5269. 7 indexed citations

Štefanič, Martin, Ralf Seemann, Vladimir A. Baulin, et al.. (2017). Apatite nanoparticles strongly improve red blood cell cryopreservation by mediating trehalose delivery via enhanced membrane permeation. Biomaterials. 140. 138–149. 62 indexed citations

Štefanič, Martin, et al.. (2014). Prediction of the in vivo performance of enteric coated pellets in the fasted state under selected biorelevant dissolution conditions. European Journal of Pharmaceutical Sciences. 62. 8–15. 10 indexed citations

Štefanič, Martin, Radmila Milačić, Goran Dražić, et al.. (2014). Synthesis of bioactive β-TCP coatings with tailored physico-chemical properties on zirconia bioceramics. Journal of Materials Science Materials in Medicine. 25(10). 2333–2345. 5 indexed citations

Štefanič, Martin, et al.. (2012). The influence of gastric emptying kinetics on the drug release from enteric coated pellets in fasted state: An in vitro/in vivo correlation. European Journal of Pharmaceutics and Biopharmaceutics. 82(2). 376–382. 23 indexed citations

Reck, Martin, R. Kaiser, Martin Štefanič, et al.. (2011). A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer. Annals of Oncology. 22(6). 1374–1381. 124 indexed citations

Reck, Martin, et al.. (2007). B1-03: Phase II double blind study to investigate efficacy and safety of the triple angiokinase inhibitor BIBF 1120 in patients suffering from relapsed advanced non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology. 2(8). S333–S334. 9 indexed citations

10.

Raymond, Éric, François Goldwasser, Guilhem Bousquet, et al.. (2007). 704 POSTER A phase I dose escalation and pharmacokinetic study of BIBF 1120, a novel tyrosine kinase inhibitor against VEGFR, PDGFR and FGFR, in combination with docetaxel in advanced chemonaive hormone refractory prostate cancer patients (HRPC). European Journal of Cancer Supplements. 5(4). 108–108. 6 indexed citations

11.

Stopfer, Peter, Willy Roth, K. Mross, et al.. (2006). 73 POSTER Pharmacokinetic characterization of BIBF 1120, an orally active triple angiokinase inhibitor (VEGFR, PDGFR, FGFR) in advanced cancer patients. European Journal of Cancer Supplements. 4(12). 26–26. 16 indexed citations

12.

Bisping, Guido, Martin Kropff, Sergey Bessonov, et al.. (2005). Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups. Blood. 107(5). 2079–2089. 28 indexed citations

13.

Mross, K., Annette Frost, Ralph Strecker, et al.. (2005). A clinical phase I, pharmacokinetic (PK), and pharmacodynamic study of twice daily BIBF 1120 in advanced cancer patients. Journal of Clinical Oncology. 23(16_suppl). 3031–3031. 19 indexed citations

14.

Buchmann, Inga, S N Reske, J. Kotzerke, et al.. (2000). Myeloablative radioimmunotherapy with Re-188-labeled anti-CD66a,b,c,e-antibody for conditioning of high-risk ALL and CML patients prior to stem cell transplantation. Blood. 96(11). 1 indexed citations

15.

Duncker, Christian, Dagmar Dohr, Stephanie von Harsdorf, et al.. (2000). Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome. Bone Marrow Transplantation. 25(12). 1263–1268. 47 indexed citations

16.

Bunjes, Donald, Christian Duncker, Markus Wiesneth, et al.. (2000). CD34+ selected cells in mismatched stem cell transplantation: a single centre experience of haploidentical peripheral blood stem cell transplantation. Bone Marrow Transplantation. 25(S2). S9–S11. 8 indexed citations

17.

Hertenstein, Bernd, Winfried V. Kern, T. Schmeiser, et al.. (1994). Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia. Annals of Hematology. 68(1). 21–26. 73 indexed citations

18.

Hertenstein, Bernd, Martin Štefanič, T Schmeiser, et al.. (1994). Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant.. Journal of Clinical Oncology. 12(5). 998–1004. 116 indexed citations

19.

Hertenstein, Bernd, et al.. (1993). Interferon-α And Donor Buffy Coat Transfusions For Treatment Of Relapsed Chronic Myeloid Leukemia After Allogeneic Bone Marrow Transplantation. Transplantation. 56(5). 1114–1118. 68 indexed citations

20.

Digel, W., Martin Štefanič, C. Buck, et al.. (1989). Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. Blood. 73(5). 1242–1246. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact